- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01805219
Global Positioning Satellite and Accelerometry to Assess Human Locomotion (ACTI GPS) (ActiGPS)
Assessment of Human Locomotion and Energy Expenditure Using Global Positioning Satellite and Accelerometry
The aim of the study is to validate the association of the GPS and accelerometer tools in order to assess the humain locomotion during exercises.
The hypotheses are:
- GPS and accelerometer together can assess the human locomotion
- GPS and accelerometer together can assess the energy expenditure during exercises
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Angers, France, 49933
- University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Older than 18
- Informed consent of the participant
- Able to understand the protocol of the study
- Register to the social health insurance
- No exercise limitation
Exclusion Criteria:
- No informed consent of the participant
- pregnant woman
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
healthy subjects
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Defining optimal analysis parameter to accurately detect walking from stopping periods
Time Frame: up to 1 week
|
Predefined walking protocols will be recorded and the subjects asked to follow recorded procedures. Detection performance of walking and resting bouts (expressed by the percentage accuracy in the detection of walking and resting bouts actually performed) for: i) GPS alone; ii) Accelerometer alone; iii) both GPS and accelerometer |
up to 1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Defining optimal analysis parameter to accurately detect speed and distance of periods of walking
Time Frame: up to 1 week
|
Predefined walking protocols will be recorded and the subjects asked to follow recorded procedures at a defined walking pace. Accuracy of speed and distance estimations (expressed by the typical error of estimate and the coefficient of variation) from: i) GPS alone; ii) Accelerometer alone; iii) both GPS and accelerometer. |
up to 1 week
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Determine the accuraccy of GPS and acceleropmetry to estimate energy expediture in healthy volunteers
Time Frame: up to 1 week
|
Recording of VO2 real time with a portable analyser in parallel to GPS and accelerometry. Prediction (determined by the coefficient of determination from linear regression) of energy expenditure during level and grade outdoor walking and running from: i) GPS alone; ii) Accelerometer alone; iii) both GPS and accelerometer. |
up to 1 week
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2012-A01411-42
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteers
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University Hospital, Clermont-FerrandUnite de Nutrition Humaine UMR 1019- INRAE; Unite MetaGenoPolis INRAE; France...CompletedHealthy Volunteers | Frail VolunteersFrance
-
Newcastle UniversityCompletedGI Glycaemic Index Healthy Volunteers | GL Glycaemic Load Healthy VolunteersUnited Kingdom
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
Galera Therapeutics, Inc.CelerionCompletedHealthy | Healthy VolunteersUnited States
-
Danone NutriciaCompletedHealthy Elderly | Healthy VolunteersChina
-
National and Kapodistrian University of AthensCompletedHealthy Adults | Healthy Volunteers OnlyGreece
Clinical Trials on GPS and accelerometer recording (s) during exercises
-
University Hospital, AngersSociété Française de Médecine VasculaireCompletedPeripheral Arterial DiseaseFrance
-
University Hospital, AngersRégion des Pays de la LoireCompletedPeripheral Artery DiseaseFrance
-
Medical University of ViennaAustrian Science Fund (FWF)Active, not recruitingHeart Failure | Artificial Heart Device UserAustria
-
Medtronic BRCMedtronic Bakken Research CenterCompleted
-
Guy's and St Thomas' NHS Foundation TrustUniversity of Oxford; Engineering and Physical Sciences Research Council, UKCompleted
-
University Hospital, GrenobleCompletedVisual Attention in Parkinson's DiseaseFrance
-
Barretos Cancer HospitalCompletedSwallowing Disorders | Head Neck CancerBrazil
-
Vanderbilt University Medical CenterEdwards LifesciencesCompletedAortic Valve StenosisUnited States
-
Charite University, Berlin, GermanySana-Klinikum Lichtenberg; Vivantes Klinikum am Urban; Park-Klinik Berlin Weißensee and other collaboratorsRecruiting
-
Alfonso MagliacanoActive, not recruitingAcquired Brain Injury | Disorders of ConsciousnessItaly